Linda Bain
CIK 1578407 · Chief Financial Officer · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$335.1K
Companies
6
Total Filings
30
Lifetime Open-Market Net
-$643.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUTL | Director | — | $1.82 | — | $0 | 1 | 2026-07-01 |
| ARVN | Director | 41,572 | $8.06 | $335.1K | $0 | 7 | 2026-06-26 |
| Codiak BioSciences, Inc. (CDAK) Delisted | Chief Financial Officer | 0 | $0.06 | $0 | -$10.1K | 8 | 2023-03-30 |
| VBI Vaccines Inc/BC (VBIV) Delisted | Director | — | $0.07 | — | $0 | 2 | 2022-01-31 |
| Adverum Biotechnologies, Inc. (AAVL) Delisted | Chief Financial Officer | 41,930 | — | — | -$253.7K | 6 | 2015-08-25 |
| bluebird bio, Inc. (BLUE) Delisted | VP, Fin. & Business Operations | 0 | $4.97 | $0 | -$380.1K | 6 | 2014-03-05 |
Recent Filings · Page 3 of 3
30 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-05-13 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Mixed | — | -$9.1K | EDGAR |
| 2015-05-12 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Mixed | — | -$22.7K | EDGAR |
| 2015-05-06 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Mixed | — | -$71.1K | EDGAR |
| 2015-04-23 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
| 2014-03-05 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$68.2K | EDGAR |
| 2014-02-12 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$20.4K | EDGAR |
| 2014-02-05 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$67.2K | EDGAR |
| 2014-01-24 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$57.5K | EDGAR |
| 2014-01-03 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$94.0K | EDGAR |
| 2013-12-18 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$37.1K | EDGAR |
Showing 21–30 of 30
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.